Mesoblast files Form 6-K with ASX press release

Q: What does Mesoblast Limited (MEOBF) report in this Form 6-K?

The Form 6-K states that Mesoblast Limited filed a news release announcement with the Australian Securities Exchange on January 9, 2026, and that this announcement is attached as Exhibit 99.1 and incorporated by reference.

Q: Who signed this Mesoblast (MEOBF) Form 6-K?

The report was signed on behalf of Mesoblast Limited by Paul Hughes, who is identified as the Company Secretary.

Q: What is included as Exhibit 99.1 to Mesoblast’s Form 6-K?

Exhibit 99.1 is described as a press release of Mesoblast Ltd dated January 9, 2026, which contains the news release filed with the Australian Securities Exchange.

Q: Does this Mesoblast (MEOBF) Form 6-K contain financial results or major transactions?

The text of the Form 6-K itself only indicates that a press release to the Australian Securities Exchange is being furnished as Exhibit 99.1; specific financial results or major transaction details would be contained in that exhibit, not in the main body provided here.

Mesoblast Limited submitted a Form 6-K as a foreign private issuer for January 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Mesoblast Limited submitted a Form 6-K as a foreign private issuer for January 2026. The company reports that on January 9, 2026 it filed a news release announcement with the Australian Securities Exchange, which is included with this submission as Exhibit 99.1 and incorporated by reference. This filing mainly serves to make that Australian disclosure available to U.S. investors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Mesoblast Limited (MEOBF) report in this Form 6-K?

The Form 6-K states that Mesoblast Limited filed a news release announcement with the Australian Securities Exchange on January 9, 2026, and that this announcement is attached as Exhibit 99.1 and incorporated by reference.

Who signed this Mesoblast (MEOBF) Form 6-K?

The report was signed on behalf of Mesoblast Limited by Paul Hughes, who is identified as the Company Secretary.

What is included as Exhibit 99.1 to Mesoblast’s Form 6-K?

Exhibit 99.1 is described as a press release of Mesoblast Ltd dated January 9, 2026, which contains the news release filed with the Australian Securities Exchange.

Why did Mesoblast Limited (MEOBF) file this Form 6-K?

The company filed this Form 6-K to furnish to U.S. investors the news release announcement it submitted to the Australian Securities Exchange on January 9, 2026, by attaching it as Exhibit 99.1.

Does this Mesoblast (MEOBF) Form 6-K contain financial results or major transactions?

The text of the Form 6-K itself only indicates that a press release to the Australian Securities Exchange is being furnished as Exhibit 99.1; specific financial results or major transaction details would be contained in that exhibit, not in the main body provided here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 01/08/2026 - 07:59 PM EST

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of January 2026

Commission File Number 001-37626

Mesoblast Limited

(Exact name of Registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s name into English)

Australia
(Jurisdiction of incorporation or organization)

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F ☑ Form 40-F ☐

INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On January 9, 2026, Mesoblast Limited filed with the Australian Securities Exchange a new release announcement, which is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

Mesoblast Limited

/s/ Paul Hughes

Paul Hughes

Company Secretary

Dated: January 9, 2026

INDEX TO EXHIBITS



Item

99.1						Press release of Mesoblast Ltd, dated January 9, 2026.

Source: View Original Filing on SEC EDGAR